Michael M. Yang's most recent trade in Ionis Pharmaceuticals Inc was a trade of 1,930 Common Stock done . Disclosure was reported to the exchange on Jan. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharma Inc | Michael J. Yang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 1,930 | 7,940 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Michael J. Yang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 1,930 | 7,150 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Michael J. Yang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 4,079 | 9,080 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Michael J. Yang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 4,079 | 6,010 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 11,518 | 11,518 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 5,220 | 13,159 | - | - | Restricted Stock Unit | |
| Pacira BioSciences Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,279 | 11,279 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,163 | 13,393 (0%) | 0% | 0 | Common Stock | |
| Hanmi Fin Corp | Michael M. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 2,849 | 30,325 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Michael J. Yang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 1,931 | 7,939 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Michael J. Yang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 1,931 | 1,931 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Michael J. Yang | Director | Purchase of securities on an exchange or from another person at price $ 12.90 per share. | 14 Aug 2024 | 2,000 | 7,230 (0%) | 0% | 12.9 | 25,800 | Common Stock |
| Ionis Pharma Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 4,079 | 9,870 | - | - | Restricted Stock Unit | |
| Pacira BioSciences Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,179 | 12,179 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 5,230 | 5,230 (0%) | 0% | 0 | Common Stock | |
| Hanmi Fin Corp | Michael M. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 4,040 | 27,476 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Michael Yang J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 5,791 | 5,791 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 12,356 | 12,356 | - | - | Non-Qualified Stock Option (right to buy) | |
| Hanmi Fin Corp | Michael M. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 4,334 | 23,436 (0%) | 0% | 0 | Common Stock | |
| Hanmi Fin Corp | Michael M. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 2,194 | 19,102 (0%) | 0% | 0 | Common Stock |